Back to search

University of Thessaly (UTH)

Η μεθυλίωση του DNA σε μονοκύτταρα του περιφερικού αίματος (PBMCs) ασθενών με αυτοάνοση ηπατίτιδα (ΑΗ) και πρωτοπαθή χολική χολαγγειίτιδα (ΠΧΧ)

Abstract

dc:description

Autoimmne hepatitis (AIH) and primary biliary cholangitis (PBC) are the two major autoimmune liver diseases, characterized by chronic inflammation of liver parenchyma that leads to end stage liver disease, if untreated. Their aetiopathognesis has not yet been completely elucidated. Since genetic factors are insufficient to explain the observed risk, the role of potential epigenetic modifications in diseases’ pathogenesis has to be clarified. The aim of the present study was to assess the contribution of epigenetic modifications in AIH and PBC pathogenesis. For this purpose, PBMCs from 10 AIH patients at diagnosis, 8 AIH patients at disease remission, 9 PBC patients and 10 healthy controls (HC) were used for further isolation of CD19(+) B and CD4(+) T lymphocytes with flow cytometry. Global DNA methylation (5mC)/hydroxymethylation (5hmC) was determined by ELISA, while the transcriptional levels of DNA methylation (DNMT1, DNMT3A, DNMT3B)/hydroxymethylation (TET1, TET2, TET3) enzymes were determined by quantitative PCR. Further analysis of the methylation level of specific CpG sites across the whole genome was performed by 850k array of Illumina. According to our findings, CD19(+) and CD4(+) lymphocytes from AIH patients at diagnosis are characterized by increased DNMT3A and reduced TET1 mRNA levels compared to PBC patients and HC respectively. DNMT3A mRNA levels are negatively associated with IgG serum levels, indicating a correlation between DNMT3A anddisease activity. Immunosuppression reduces DNMT3A levels in both CD19(+) and CD4(+) lymphocytes from AIH patients at disease remission. Interestingly, changes in DNMT3A and TET1 expression have no effect on global 5mC/5hmC levels in CD19(+) and CD4(+) cells from AIH patients, supporting the probable presence of differential methylation of isolated genes. This fact is futher supported by the methylation analysis across the whole genome, which revealed hypomethylation of several genes in AIH, in contrast to the hypermethylation of the majority of the differentially methylated genes in PBC. In addition, the hypomethylation of certain genes in AH patients at diagnosis is reversed after treatment administration. Some of the most differentially methylated genes were involved in pathways of innate immunity, development of cholestatis and of hepatocellular carcinoma. Last but not least, our study highlights the role of the X chromosome in PBC pathogenesis, a finding that is not verified in AIH. In conclusion, our study supports that AIH is characterized by altered expression of DNA methylation/hydroxymethylation enzymes, which is associated with disease activity, but also by hypomethylation of specific genes involved in immune pathways, which is reversed by immunosuppressive treatment. These findings open new insights in understanding disease’s pathogenesis and establishing novel, targeted therapeutic interventions.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Arvaniti, Pinelopi
  • Αρβανίτη, Πηνελόπη

Subjects

dc:subject × 11

Rights

dc:rights
Statement dc:rights
  • BY_NC_ND
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/48164

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Arvaniti, Pinelopi; Αρβανίτη, Πηνελόπη. Η μεθυλίωση του DNA σε μονοκύτταρα του περιφερικού αίματος (PBMCs) ασθενών με αυτοάνοση ηπατίτιδα (ΑΗ) και πρωτοπαθή χολική χολαγγειίτιδα (ΠΧΧ). University of Thessaly (UTH), 2020. http://hdl.handle.net/10442/hedi/48164